RaySearch Laboratories AB (publ) has announced that the Kingdom of Morocco’s Ryad Oncologia Clinic and two Groupe Les Oliviers sites have become the first cancer centers in North Africa to order treatment planning system RayStation®️*. RayStation has been chosen to provide access to advanced treatment planning features that were previously unavailable in the North African market.
RayStation is marketed locally by AROS, a company created by American Board of Radiology-certified medical physicists. AROS is committed to delivering exceptional patient care through close collaboration with the clinicians at cancer centers such as Ryad Oncologia Clinic and Groupe Les Oliviers.
Ryad Oncologia Clinic in Casablanca is one of Morocco’s largest and most distinguished private oncology centers. Led by Professor A. Acharki, Ryad provides end-to-end cancer care with surgery and chemotherapy offered in addition to radiation therapy. The radiation therapy division treats more than 150 patients per day.
Professor A. Acharki, CEO, says: “I discovered RayStation during ESTRO 2018 in Milan, Italy, and again at SFRO in Paris. I was amazed by the ease of use and the different services it offers. As a radiation oncologist, I can only say good things about this treatment planning system. RayStation makes it easier and quicker to plan treatment – especially with automatic contouring – which is important as time is something doctors are sorely in need of. I can also attest to the joy of our physicists, who describe it as fast, precise, and concrete. RayStation is the third treatment planning system we have installed, so we know what we’re talking about.”
Groupe Les Oliviers is a growing network of clinics in Morocco thanks to a partnership with Group ELSAN, a major player in the French healthcare sector. Groupe Les Oliviers plans to open its first radiation therapy clinic in July 2020 in Settat, and its second in 2021 in Beni Mellal. Both sites will use RayStation as their sole treatment planning system.
Group president Dr. El Maati Er Rachiq says: “We are very pleased to be the first cancer center in Morocco to exclusively use RayStation for treatment planning. The choice was made by our radiation oncologists, whom we fully trust in making the right choices for our patients. We are confident that RaySearch and AROS will provide us with all the support we need to utilize RayStation to its fullest potential for the maximum benefit of our patients.
Johan Löf, founder and CEO, RaySearch, says: “Entering any new market is an exciting milestone for RaySearch and advanced software systems designed to improve clinical workflows and the precision of radiation therapy treatment. Growth prospects for the oncology market are positive for Morocco and the North African region and we pledge to work closely with AROS to provide cancer centers there with access to the latest technological developments for advancing cancer treatment.”
This order was received in Q1/2020 and the majority of the revenue was received during the same period.
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets worldwide its treatment planning system RayStation and next-generation oncology information system RayCare. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.
* Subject to regulatory clearance in some markets.
More information about RaySearch is available at www.raysearchlabs.com
For further information, please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59